Related references
Note: Only part of the references are listed.The potential of ghrelin in the treatment of cancer cachexia
Josep M. Argiles et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Hypothalamic neuropeptides and the regulation of appetite
Jennifer A. Parker et al.
NEUROPHARMACOLOGY (2012)
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Yoshifumi Imazu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
The parallel pathway: a novel nutritional and metabolic approach to cancer patients
Maurizio Muscaritoli et al.
INTERNAL AND EMERGENCY MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Ghrelin, appetite and gastric electrical stimulation
Syrine Gallas et al.
PEPTIDES (2011)
Effects of Ghrelin Administration After Total Gastrectomy: A Prospective, Randomized, Placebo-Controlled Phase II Study
Shinichi Adachi et al.
GASTROENTEROLOGY (2010)
Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease
Rocco Barazzoni et al.
KIDNEY INTERNATIONAL (2010)
Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: Role as regulators of food intake and body weight
Andreas Stengel et al.
PEPTIDES (2010)
Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction
Kazuyoshi Yamamoto et al.
SURGERY (2010)
Neuropeptides in the pathophysiology and treatment of cachexia
Stephanie M Krasnow et al.
Current Opinion in Supportive and Palliative Care (2010)
Contribution of anorexia to tissue wasting in cachexia
Alessio Molfino et al.
Current Opinion in Supportive and Palliative Care (2010)
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment
Damien R. Ashby et al.
KIDNEY INTERNATIONAL (2009)
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia:: a randomised, placebo-controlled, double-blind, double-crossover study
F. Strasser et al.
BRITISH JOURNAL OF CANCER (2008)
Ghrelin treatment of chronic kidney disease: Improvements in lean body mass and cytokine profile
Mark D. DeBoer et al.
ENDOCRINOLOGY (2008)
NPY and brain monoamines in the pathogenesis of cancer anorexia
Alessandro Laviano et al.
NUTRITION (2008)
Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia
Mark D. DeBoer et al.
ENDOCRINOLOGY (2007)
Treatment of cachexia with ghrelin in patients with COPD
N Nagaya et al.
CHEST (2005)
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: A randomized, placebo-controlled trial
K Wynne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure
N Nagaya et al.
CIRCULATION (2004)
Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
NM Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)